Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

ClinicalTrials.gov ID: NCT01156415

Public ClinicalTrials.gov record NCT01156415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-week, Multi-center, Open-label Study of the Safety and Tolerability of Agomelatine Sublingual Tablets in Patients With Major Depressive Disorder (MDD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will assess safety and tolerability of 0.5 mg/day and 1 mg/day of sublingual (under the tongue) formulation of agomelatine (AGO178) in patients with Major Depressive Disorder over a 52-week open-label phase. Cohort I is restricted to include patients who have completed a previous Novartis agomelatine (178C) Double-blind study. Cohort II will include de-novo patients (those who did not participate in a previous agomelatine 178C study) and will only be open for a limited time span ranging from approximately June to Sept 2010, at which point this cohort II will be closed to enrollment.

Study identification

NCT ID
NCT01156415
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
837 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 71 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2010 (Type not available)
Primary completion
Oct 2011 (Actual)
Completion
Oct 2011 (Actual)
Last update posted
Dec 24, 2020

2010 – 2011

United States locations

U.S. sites
95
U.S. states
31
U.S. cities
84
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Advanced Research Associates Glendale Arizona 85308 —
Southwest Health Ltd dba The Mollen Clinic Scottsdale Arizona 85254 —
Clinical Study Centers, LLC Little Rock Arkansas 72205 —
Southwestern Research Institute Beverly Hills California 90210 —
Comprehensive Neuroscience Cerritos California 90703 —
ATP Clinical Research, Inc Costa Mesa California 92626 —
Collaborative Neuroscience Network Garden Grove California 92845 —
Pharmacology Research Institute Newport Beach California 92660 —
Pacific Clinical Research Medical Group Orange California 92868 —
CNRI-San Diego, LLC San Diego California 92102 —
University of California, San Diego Medical Center San Diego California 92103 —
Neuropsychiatric Research Center of Orange County Santa Ana California 92701 —
Viking Clinical Research Center Temecula California 92591 —
Collaborative Neuroscience Torrance California 90502 —
University of Colorado Aurora Colorado 80045 —
Western Affiliated Research Institute Denver Colorado 80209 —
Middlesex Hospital Middletown Connecticut 06457 —
Clinical Studies Altamonte Springs Florida 32701 —
Florida Clinical Research Center, LLC Bradenton Florida 34208 —
Arocha Research Center Coral Gables Florida 33134 —
CNS Clinical Research Coral Springs Florida 33067 —
Sjs Clinical Research Destin Florida 32541 —
MD Clinical Hallandale Florida 33009 —
CNS Healthcare Jacksonville Florida 32216 —
Florida Clinical Research Center Maitland Florida 34201 —
CNS Healthcare Orlando Florida 32806 —
Quantum Lab. at N. Broward Memory Disorder Center Pompano Beach Florida 33064 —
Miami Research Associates South Miami Florida 33143 —
Comprehensive NeuroScience, Inc. St. Petersburg Florida 33716 —
Janus Center for Psychiatric Research West Palm Beach Florida 33407 —
Emory University Atlanta Georgia 30306 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Northwest Behavioral Research Center Marietta Georgia 30060 —
Hawaii Clinical Research Center Honolulu Hawaii 96813 —
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169 —
Joliet Center for Clinical Research Joliet Illinois 60435 —
Capstone Clinical Research Libertyville Illinois 60048 —
Rush University Medical Center Skokie Illinois 60076 —
Deaconess Clinic Gateway Newburgh Indiana 47630 —
Pharmasite Research Pikesville Maryland 21208 —
Boston Clinical Trials Boston Massachusetts 02135 —
Mount Auburn Medical Associates Watertown Massachusetts 02472 —
Coastal Research Associates Weymouth Massachusetts 02190 —
Michigan State University East Lansing Michigan 48824 —
Pine Rest Christian Mental Health Services Grand Rapids Michigan 49548 —
Rochester Center for Behavioral Medicine Rochester Hills Michigan 48307 —
Comprehensive Psychiatric Associates Gladstone Missouri 64118 —
Robert Wood Johnson Medical School Piscataway New Jersey 08854 —
Bio Behavioral Health Toms River New Jersey 08755 —
CRI Worldwide Willingboro New Jersey 08046 —
Albuquerque Neuroscience Albuquerque New Mexico 87109 —
Neurological Associates Of Albany Albany New York 12208 —
Social Psychiatry Research, Inc./ SPRI Brooklyn New York 11235 —
Neurobehavioral Research, Inc. Cedarhurst New York 11516 —
Eastside Comprehensive Medical Service New York New York 10021 —
Medical & Behavior Health Research New York New York 10023 —
The Medical Research Network, LLC New York New York 10128 —
Richmond Behavioral Associates Staten Island New York 10312 —
Montefiore Medical Center The Bronx New York 10467 —
Pharmquest Greensboro North Carolina 27408 —
Zarzar Psychiatric Associates Raleigh North Carolina 27607 —
Piedmont Medical Research Associates, Inc. Winston-Salem North Carolina 27103 —
Odyssey Research Services Fargo North Dakota 58104 —
Neuro Behavioral Clinical Research Canton Ohio 44718 —
University of Cincinnati Medical Center Cincinnati Ohio 45219 —
North Star Medical Research Cleveland Ohio 44130 —
The Ohio State Universtiy - Harding Hospital Columbus Ohio 43210 —
Neurology & Neuroscience Center of Ohio Toledo Ohio 43623 —
IPS Research Oklahoma City Oklahoma 73103 —
SP Research Oklahoma City Oklahoma 73112 —
Cutting Edge Research Oklahoma City Oklahoma 73116 —
Sunstone Medical Research, LLC Medford Oregon 97504 —
Oregon Center for Clinical Investigations Portland Oregon 97210 —
Summit Research Portland Oregon 97210 —
Lehigh Center for Clinical Research Allentown Pennsylvania 18104 —
Suburban Research Associates Media Pennsylvania 19063 —
CRI Worldwide, LLC Philadelphia Pennsylvania 19139 —
Medical University of South Carolina Charleston South Carolina 29406 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
Research Strategies of Memphis Memphis Tennessee 38119 —
Clinical Research Associates Nashville Tennessee 37203 —
Millwood Hospital Arlington Texas 76011 —
FutureSearch Trials of Dallas Dallas Texas 75231 —
InSite Clinical Research DeSoto Texas 75115 —
Bayou City Research Limited Houston Texas 77007 —
Claghorn Lesem Research Clinic, Inc. Houston Texas 77008 —
Texas Center for Drug Development Houston Texas 77081 —
Grayline Clinical Drug Trials Wichita Falls Texas 76309 —
Radiant Research Salt Lake City Utah 84107 —
University of Utah Mood Disorders Clinic Salt Lake City Utah 84132 —
Alliance Research Group, LLC Richmond Virginia 23230 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Frontier Institute Spokane Washington 99204 —
Independent Psychiatric Consultants Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01156415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 24, 2020 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01156415 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →